Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. [electronic resource]
Producer: 19950130Description: 199-208 p. digitalISSN:- 0098-7484
- Aged
- Cholesterol, HDL -- blood
- Double-Blind Method
- Drug Administration Schedule
- Endometrial Hyperplasia -- chemically induced
- Estrogen Replacement Therapy
- Estrogens, Conjugated (USP) -- administration & dosage
- Female
- Fibrinogen -- drug effects
- Glucose -- metabolism
- Heart Diseases -- epidemiology
- Humans
- Insulin -- blood
- Medroxyprogesterone Acetate -- administration & dosage
- Middle Aged
- Postmenopause -- drug effects
- Risk Factors
- Systole -- drug effects
- Weight Gain
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.